Unraveling Emerging Anal Cancer Clinical Biomarkers from Current Immuno-Oncogenomics Advances
Open Access
- 24 January 2024
- journal article
- review article
- Published by Springer Nature in Molecular Diagnosis & Therapy
- Vol. 28 (2) , 201-214
Abstract
Anal squamous cell carcinoma (ASCC) is a rare gastrointestinal malignancy associated with high-risk human papillomavirus (HPV) and is currently one of the fastest-growing causes of cancer incidence and mortality in developed countries. Although next-generation sequencing technologies (NGS) have revolutionized cancer and immuno-genomic research in various tumor types, a limited amount of clinical research has been developed to investigate the expression and the functional characterization of genomic data in ASCC. Herein, we comprehensively assess recent advancements in “omics” research, including a systematic analysis of genome-based studies, aiming to identify the most relevant ASCC cancer driver gene expressions and their associated signaling pathways. We also highlight the most significant biomarkers associated with anal cancer progression, gene expression of potential diagnostic biomarkers, expression of therapeutic drug targets, and emerging treatment opportunities. This review stresses the urgent need for developing target-specific therapies in ASCC. By illuminating the molecular characteristics and drug-target expression in ASCC, this study aims to provide insights for the development of precision medicine in anal cancer.Keywords
Funding Information
- Fondation Nelia et Amadeo Barletta
- National Cancer Institute (U54-CA221208)
This publication has 112 references indexed in Scilit:
- APOBEC-Mediated Cytosine Deamination Links PIK3CA Helical Domain Mutations to Human Papillomavirus-Driven Tumor DevelopmentCell Reports, 2014
- Modulation of Apoptotic Pathways by Human Papillomaviruses (HPV): Mechanisms and Implications for TherapyViruses, 2012
- Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/CisplatinJournal of Clinical Oncology, 2012
- DNA Methylation Profiling across the Spectrum of HPV-Associated Anal Squamous NeoplasiaPLOS ONE, 2012
- Human Papillomavirus Type 8 Interferes with a Novel C/EBPβ-Mediated Mechanism of Keratinocyte CCL20 Chemokine Expression and Langerhans Cell MigrationPLOS Pathogens, 2012
- Human Papillomavirus Deregulates the Response of a Cellular Network Comprising of Chemotactic and Proinflammatory GenesPLOS ONE, 2011
- Prognostic factors derived from a prospective database dictate clinical biology of anal cancerCancer, 2010
- Human papillomavirus oncoproteins: pathways to transformationNature Reviews Cancer, 2010
- Decreased Migration of Langerhans Precursor-Like Cells in Response to Human Keratinocytes Expressing Human Papillomavirus Type 16 E6/E7 Is Related to Reduced Macrophage Inflammatory Protein-3α ProductionJournal of Virology, 2005
- DNA Methylation in Anal Intraepithelial Lesions and Anal Squamous Cell CarcinomaClinical Cancer Research, 2005